Who founded Rosebud Biosciences?

Rosebud Biosciences was founded by Kitch Wilson, Evan Lyall in 2020.

Who are Rosebud Biosciences's investors?

Rosebud Biosciences's investors include Y Combinator.

Where is Rosebud Biosciences headquartered?

Rosebud Biosciences is headquartered in San Francisco, US.

Rosebud Biosciences

YC W22

San Francisco, US · Founded 2020 · 3 employees · 1 known investors

Find your way into Rosebud Biosciences

2,048 people in our graph share verified history with the Rosebud Biosciences team — schools, employers, funds. One of them is your warm intro.

Deep Nisharunlockedknows Kitch Wilson · together at Stanford University (overlapped)

×10knows the team · via Stanford University

knows the team · via University of California, Berkeley

Rosebud Biosciences develops therapies for rare genetic diseases in children by creating organoid models that replicate patient genetic mutations and using drug screening to identify potential cures. The company uses human-derived organoids combined with robotics and machine learning to accelerate drug discovery across cardiac, hepatic, neural, and kidney disease targets.

Also known as Rosebud Biosciences Inc.

Biotech Deep Tech Healthtech Medical Devices AI-powered Drug Discovery PediatricsUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (W22)

Rosebud Biosciences was founded in 2020 by Kitch Wilson and Evan Lyall.

Kitch Wilson in 𝕏Co-founder and CEOKitch Wilson is a physician and molecular biologist with over 15 years of experience in induced pluripotent stem cell research and genomic technologies. He completed medical and doctoral training at Stanford, where he spent six years as an attending physician before co-founding Rosebud Biosciences.

Evan Lyall in 𝕏Co-founder and CTOHe holds a PhD and has spent a decade in advanced microscopy, machine learning, and data engineering, including research at UC Berkeley on neural coding and brain-machine interfaces, followed by contract data and ML engineering roles at early-stage companies.

Investors · 1

Y CombinatorSan Francisco · $500K

The YC application· Winter 2022 batch

▶ Demo Day video — watch on YC ↗

What they told YC

How long have each of you been working on this? How much of that has been full-time? Please explain.: Kitch, the CEO, started working full-time on the company's business plan and platform concept in June 2020, and Evan joined full-time as cofounder and CTO in January 2021.

Summarized from the founders' answers on their Y Combinator profile.

In the news

Creation of vascularized mini-organs marks milestone in regenerative medicine | Stanford Reportnews.stanford.edu · Jun 2025

Our favorite startups from YC's Winter 2022 Demo Day, part 1techcrunch.com · Mar 2022

Frequently asked questions

What does Rosebud Biosciences do?: Rosebud Biosciences develops therapies for rare genetic diseases in children by creating organoid models that replicate patient genetic mutations and using drug screening to identify potential cures. The company uses human-derived organoids combined with robotics and machine learning to accelerate drug discovery across cardiac, hepatic, neural, and kidney disease targets.
Who founded Rosebud Biosciences?: Rosebud Biosciences was founded by Kitch Wilson, Evan Lyall in 2020.
Who are Rosebud Biosciences's investors?: Rosebud Biosciences's investors include Y Combinator.
Where is Rosebud Biosciences headquartered?: Rosebud Biosciences is headquartered in San Francisco, US.